News AbbVie taking on Gilead with eight-week hep C course Latest combination drug resulted in 97.5% cure rates across all major disease strains
News GSK/Janssen's rheumatoid arthritis drug filed in EU Drug could compete against Sanofi rival if approved.
News Brexit could marginalise UK life sciences - expert Cancer doctor concerned over impact on life sciences R&D.
News Zepatier to add competition to Europe’s hep C market Will company pursue same aggressive pricing strategy in Europe?
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
